MENU
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vir Biotechnology (VIR) Ownership - Who owns Vir Biotechnology?
Profile
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.01B
P/E Ratio
N/A
Total Cash
914.47M
Projected Growth
N/A
Total Debt
112.81M
Revenue
62.04M
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
6.64
Total Debt/Equity
N/A
Revenue/Share
0.46 USD as % of share price
Fundamentals
VIR
Capitalization
1.01B
P/E Ratio
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash
914M
Total Cash/Share
6.64
Total Debt
113M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.46%
Revenue
62M
ROE
N/A
Book Value
1.24B
P/B Ratio
0.81
Cash Flow
N/A
Earnings
-3.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
8.94
Current Revenue Per Employee
492.33
Dividends Per Share - Security
N/A
EBITDA
-562.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.70
Revenue To Assets
-30.10
Shares Held By Institutions
1.05B
Shares Outstanding - Current
138M
Total Liabilities
258M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.038
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio